Endoscopic treatment modalities and outcomes in nonvariceal upper gastrointestinal bleeding

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 2

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Endoscopy

ISSN

1948-5190

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Gastrointest Endosc. Feb 16, 2020; 12(2): 72-82
Published online Feb 16, 2020. doi: 10.4253/wjge.v12.i2.72

Table 3 Outcomes, n (%)

Outcomes	Number (n = 161)
Rebleeding
Yes	42 (26.1)
No	119 (73.9)
Need for repeat endoscopy
Yes	47 (29.2)
No	114 (70.8)
Need for surgery
Yes	1 (0.6)
No	160 (99.4)
Transfusion requirement
-Number of units of PRBC’s (Median/IQR)	2/0-3
Length of hospital stay
-Number of days (Median/IQR)	6/4-13
Death during same admission
Yes	10 (6.2)
No	151 (93.8)
30-d mortality
Yes	0
No	151 (93.8)

PRBC: Packed red blood cell; IQR: Interquartile range.

Citation: Yip BCH, Sayeed Sajjad H, Wang JX, Anastassiades CP. Endoscopic treatment modalities and outcomes in nonvariceal upper gastrointestinal bleeding. World J Gastrointest Endosc 2020; 12(2): 72-82
URL: https://www.wjgnet.com/1948-5190/full/v12/i2/72.htm
DOI: https://dx.doi.org/10.4253/wjge.v12.i2.72

Yip BCH, Sayeed Sajjad H, Wang JX, Anastassiades CP. Endoscopic treatment modalities and outcomes in nonvariceal upper gastrointestinal bleeding. World J Gastrointest Endosc 2020; 12(2): 72-82 [PMID: 32064032 DOI: 10.4253/wjge.v12.i2.72]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.